Michigan Supreme Court expands consumer protection, curbing Eli Lilly insulin price gouging

On July 31 2026 the Michigan Supreme Court issued a landmark ruling that overturns earlier exemptions in the Michigan Consumer Protection Act (MCPA). The decision ends a 25‑year loophole that shielded businesses with state or federal licenses from price‑gouging claims, allowing the Act to apply to any unfair or deceptive practice, including the pricing of insulin sold by Eli Lilly.

State Rep. Kelly Breen praised the ruling as a victory for Michigan consumers, while Attorney General Dana Nessel highlighted the court’s role in protecting families from exploitative pricing. The judgment is expected to broaden MCPA enforcement and could set a precedent for other regulated industries in the state.